Skip to main content

Advertisement

Characterization of Conserved Combined T and B Cell Epitopes in Leptospira interrogansMajor Outer Membrane Proteins OmpL1 and LipL41

BMC Microbiologyvolume 11, Article number: 21 (2011) | Download Citation

Article metrics

  • 4214 Accesses

  • 16 Citations

Abstract

Background

Leptospira interrogans are bacterial pathogens of animal that cause zoonotic infections in human. Outer membrane proteins of leptospire are among the most effective antigens which can stimulate remarkable immune responses during the infection processes, and thus are currently considered leading candidate vaccine antigens. The objective of the present study is to predict and confirm major combined B and T cell epitopes of leptospiral outer membrane proteins OmpL1 and LipL41, as well as to evaluate their capacity in the induction of immune responses in BALB/c mice.

Results

In this study, four epitopes from OmpL1 and four from LipL41 conserved regions were evaluated for their potential utilization in leptospire vaccines. Firstly, combined B and T cell epitopes were predicted by softwares and expressed using a phage display system. OmpL1 residues 87-98 and 173-191 (OmpL187-98 and OmpL1173-191) and LipL4130-48, LipL41233-256 of LipL41 were identified as immunodominant B cell epitopes by Western blot. Epitopes OmpL1173-191, OmpL1297-320 of OmpL1 and LipL41233-256, LipL41263-282 of LipL41 were identified as immunodominant CD4+ T cell epitopes through proliferation analysis of splenocytes from recombinant OmpL1 (rOmpL1) or recombinant LipL41 (rLipL41)-immunized BALB/c (H-2d) mice. These epitopes induced responses of CD4+ T cells and Th1 (T helper cells) type cytokine responses during the infection.

Conclusion

This work identified combined T and B cell immunodominant epitopes in outer membrane proteins OmpL1 and LipL41 of Leptospira interrogans. OmpL1173-191 of OmpL1 and LipL41233-256 of LipL41 could be useful in a vaccine against Leptospira. The findings could also contribute to the development of effective cross-protective vaccine strategies for leptospirosis.

Background

One of the emerging health problems in poor urban slum communities in developing countries is leptospirosis caused by pathogenic Leptospira, which is the most widespread zoonotic disease[1].

The immune responses to leptospires appear complex. Both animal model and human clinical studies have indicated that during the infection, leptospires can still persistently present despite robust immune responses suggesting that leptospires are capable of evading both innate and adaptive immunity and the immune responses triggered by leptospires in nature are not effective in the elimination of this pathogen [2]. Accumulating evidence support a key role for CD4+ T cells in the acute and chronic stages of the infection in many bacterial diseases [3–5]. Immunity is specific for leptospiral types that have closely related agglutinating antigens, that is, the same or closely related serovars [6]. At present, the full genome sequences of some Leptospira strains have been sequenced [7–10], but the target antigens which are important in the induction of the host immune responses during infection have not been fully identified.

Leptospiral outer membrane proteins exposed on the leptospiral surface are conserved proteins among pathogenic Leptospira and are potentially associated with pathogenesis, and have become a major focus of current leptospiral vaccine research [11]. Some evidence has shown that outer membrane proteins play a critical role in the infection of Leptospira, because these proteins are at the interface between the pathogen and the mammalian host immune responses [12, 13]. OmpL1 and LipL41 are antigenically conservative among pathogenic Leptospira species; their promise as vaccine candidates is enhanced by the finding that OmpL1 and LipL41 are expressed during infection of the mammalian host [14, 15]. Recombinant outer membrane proteins OmpL1 and LipL41 were used as subunit vaccines and the protective effects were synergistic in a hamster model of leptospirosis [16].

In the present study, we expressed selected combined T and B cell epitopes of OmpL1 and LipL41 using a phage display system, and evaluated their ability of antibody recognition, as well as stimulation of T lymphocyte proliferation and cytokine expression.

Methods

Materials

Leptospira interrogans serovar Lai strain, used as the template in the amplification of epitope fragments, was cultured in EMJH medium. Escherichia coli DH10B was used as the host strain for the transformation. Phage display kit was purchased from New England Biolabs (Massachusetts, USA). Endonucleases, pGEM-T easy vector were obtained from Promega (Wisconsin, USA). 20-bp DNA ladder was bought from TaKaRa Bio (Dalian, China) Co., Ltd. Goat anti-human IgG-horseradish peroxidase (HRP) was from Jackson ImmunoResearch (Pennsylvania, USA), and goat anti-rabbit IgG-HRP was bought from Santa Cruz (California, USA). UltraEAL Western Blot Detection System was purchased from Shanghai Generay Biotech Co., Ltd (Shanghai, China). Protein molecular weight marker, lymphocyte separation medium (mouse), mitomycin and CCK-8 kit were purchased from Beyotime Institute of Biotechnology (Jiangsu, China). ELISA kits for IFN-γ or IL-4 were purchased from R&D Systems (Minnesota, USA). Sera from L. interrogans, recombinant protein OmpL1- or LipL41-immunized rabbits were produced as previously described [17, 18]. Sera of leptospirosis patients were obtained from hospitals in Guangdong, Sichuan and Zhejiang provinces [19]. 6-8 week old female BALB/c mice were procured from the Experimental Animal Center of Zhejiang University and raised under pathogen-free environment. All the animal experiments were approved by the institutional review board.

Prediction of T and B cell epitopes

The combined T and B cell epitopes were predicted based on the amino acid sequences of OmpL1 and LipL41 (GenBank accession codes AAT48511 and AAT48493). To avoid the epitopes located in the signal peptide region, SignalP 3.0 Server (http://www.cbs.dtu.dk/services/SignalP/) was used to predict the signal peptides. ANTIGENIC program in EMBOSS (http://beta.immuneepitope.org/) was used to predict B cell epitopes and ProPred, a web tool useful in the prediction of HLA-DR binding sites (http://www.imtech.res.in/raghava/hlapred/) [20], was used to predict potential T cell epitopes.

Extraction of genomic DNA

The genomic DNA of L. interrogans Lai strain was extracted by proteinase K treatment and phenol-chloroform extraction method as described previously [21]. The precipitated genomic DNA was resuspended in 100 μl sterilized water, 10 μl 3 M sodium acetate and 220 μl absolute alcohol and stored at -20°C. Before use, DNA was precipitated by centrifugation and was resuspended in sterilized water.

Expression and purification of epitope peptides

Sequences of 4 predicted epitopes from OmpL1 and 4 from LipL41 were amplified from genomic DNA. The primers used to amplify the fragments of selected epitopes were shown in Table 1. EcoR52 I site and a 14 bp leader peptide sequence of M13KE were located at the 5' end of each forward primer, and Kpn I was introduced at the 5' end of reverse primer. The amplified fragments were inserted into pGEM-T easy vector for sequencing. Then each of the sequence-confirmed fragment was subcloned into EcoR52 I and Kpn I sites of the phage vector M13KE. Primers M13PF 5'-GAGATTTTCAACGTGAAAAAATTATT-3' and M13PR 5'-TGAATTT TCTGTATGGGATTTTGCTA-3' were designed based on the sequence of PIII gene in M13KE and were used to determine the insertions of each epitope by colony PCR. Positive clones were further confirmed by sequencing.

Table 1 Primers for amplifying epitopes of OmpL1 and LipL41
Full size table

The proliferation and purification of phage was reported previously [22]. E. coli ER2738 was inoculated in 30 mL LB culture medium and incubated with shaking at 37°C for 2 h. Each recombinant phage was used to infect ER2738, and the culture was incubated with vigorous aeration at 28°C for 4 h. After centrifugation at 10 000 rpm for 10 min at 4°C, the medium supernatant containing phage was transferred to a clean tube and mixed with 1/6 volume of 20% polyethylene glycol 8000 (PEG 8000)-2.5 M NaCl and incubated at 4°C overnight. The phage was pelleted by centrifugation at 11 000 rpm for 15 min at 4°C and resuspended in 1 ml TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). The phage was reprecipitated by adding 1/6 volume of 20% PEG 8000-2.5 M NaCl and incubation on ice for 1 h. Finally, the recombinant phage was collected by centrifugation at 11 000 rpm for 15 min at 4°C and resuspended in TBS. The OD values at wavelength 269 and 320 were determined and used to calculate the number of phage particles according to the method of Day described previously [23].

Identification of B cell epitopes

Western blot assay was used to detect the reactivity of B cell epitope with antibodies in the rabbit sera raised against L. interrogans, rOmpL1 or rLipL41. Purified recombinant phage particles (3 × 1014) were separated by electrophoresis in an 8% SDS-PAGE gel and then transferred to a polyvinylidene fluoride membrane (PVDF, Millipore). The membrane was blocked in 6% newborn bovine serum-TBST (Tris buffered saline; 0.1% Tween 20, pH 7.2) for 1 h and incubated overnight at 4°C with rabbit serum against leptospira Lai (dilution 1:200, MAT more than 1:400) followed by blotting with HRP-conjugated goat anti-rabbit antibodies (dilution 1:5000) for about 1 h at 37°C. Blots were developed using enhanced chemiluminescence reagents and exposed to X-ray films. In some cases, the blots were reprobed using rabbit serum against rOmpL1 or rLipL41(dilution 1:300) after stripping off the first antibody by incubation in the stripping buffer (65 mM Tris-HCl pH 6.7, 100 mM beta-mercaptoethanol, 2% SDS). Wild type M13KE particles were used as controls.

The reactivity of each epitope with antiserum mixture from IgM- and IgG-positive leptospirosis patients who were infected by different leptospiral serovars was also evaluated by Western blot [21]. IgM- and IgG-positive serum samples from leptospire-infected humans were pooled together and used as primary antibody (1:50 dilution). The antisera were incubated with the PVDF membrane at 37°C for about 1.5 h. After a washing step, goat anti-human IgG-HRP (1:5000 dilution) was used as secondary antibody. Wild type M13KE particles were also used as controls.

Mice and immunization

100 μg rOmpL1 or rLipL41 protein pre-mixed with complete Freund's adjuvant (Sigma) was used to inject subcutaneously in the four limbs of 6-8 week old female BALB/c (H-2d) mice,. Same dose of proteins for boosting immune responses were given with incomplete Freund's adjuvant (Sigma) two weeks later. After 10 days, the mice were used for further experiments. Control mice were administered with PBS by the same procedures.

Detection of T cell response

For the analysis of specific CD4+ T cell proliferation, spleens were aseptically removed and mechanically homogenized with a 3-ml syringe plunger, and then splenocytes were isolated by lymphocyte separation medium (mouse) according to the manufacturer's instruction. Complete RPMI 1640 media (RPMI-1640, 10% fetal bovine serum, 2 mM glutamine, 50 U of penicillin/ml, 50 μg of streptomycin/ml, 50 μM 2-mercaptoethanol, and 25 mM HEPES) was used to cultivate the cells.

100 μl isolated T cells (5 × 104 cells per well) and mitomycin-inactivated allogeneic splenocytes (105 cells per well) were seeded into 96-well flat bottom culture plates and restimulated in vitro with different epitopes at a concentration of 5 × 1014 recombinant phage particles per cell. 5 μg/ml mitogen concanavalin A (ConA) was used as control. Cells were incubated at 37°C with 5% CO2 for 72 h. The cell proliferation was measured using Cell Counting Kit (CCK)-8 according to the manufacturer's instruction. Briefly, 20 μl CCK solution was added to the culture medium and incubated for additional 3 h. The absorbance was determined at 450 nm with a 630 nm reference wavelength using ELISA Reader (Bio-Rad). Unstimulated cells were used as negative control and ConA-stimulated cells were used as positive control. Tests were repeated at least three times independently. Phages expressing each epitope were mixed together to evaluate if there is synergistic effect of these epitopes in the stimulation of the splenocytes isolated from the immunized mice.

Effect of each epitope peptide on the secretion of cytokines

Th1 (IFN-γ) or Th2 (IL-4) cytokine secretion was examined. IFN-γ or IL-4 ELISA kit was used to evaluate the cytokine level in 100 μl T lymphocyte cell culture supernatants according to the manufacturer's instruction. Production of each cytokine was calculated through the titration of the supplied calibrated cytokine standards.

Statistical analysis

Figures represent data from three independent experiments shown as mean ± SD. Microsoft office Excel was used to analyze variance and identify significant differences.

Results

Prediction and expression of combined T and B cell epitopes of OmpL1 and LipL41

The online softwares were used to map the combined B and T cell epitopes in OmpL1 and LipL41. Eight high-score combined T and B cell epitopes, including 4 OmpL1 epitopes and 4 LipL41 epitopes were selected as candidates for peptide expression and immunological analysis (Table 2).

Table 2 The sequences of selected epitopes from OmpL1 and LipL41.
Full size table

Each selected epitope of OmpL1 and LipL41 was first amplified from genomic DNA of Lai strain [Additional file 1], and then subcloned into the EcoR52 I and Kpn I sites of phage vector M13KE. The insertion of each epitope into the recombinant phage was confirmed by colony PCR [Additional file 2]. The sequences of the epitopes in the recombinant phage were confirmed via sequencing. Then the recombinant phage DNA was used to transform E. coli ER2738 competent cells. The recombinant phage particles were purified and separated on an 8% SDS-PAGE gel. Wild type phage M13KE was used as control. As shown in Figure 1A, after visualization by in-gel protein staining, there was a single band in each lane near 63-66 kD which was close to the molecular weight of M13KE (about 63 kD) according to the protein ladder.

Figure 1
figure1

SDS-PAGE and Western blot analysis of epitope-expressing phages. 3 × 1014 purified phage particles were separated by SDS-PAGE gel and transferred to PVDF membrane for Western blot assay. A is SDS-PAGE analysis of purified recombinant phage particles. B and C are the Western blot results, using rabbit sera against Leptospira interrogans or recombinant proteins. D is the result using sera mixture from five IgG- and IgM- positive leptospire patients. Lane M, protein ladder; lane 1, wild type M13KE particles; lane 2-5, recombinant phage particles containing epitope fragments 58-78, 87-98, 173-191 and 297-320 from OmpL1; lane 6-9, recombinant phage particles containing epitope fragments 30-48, 181-195, 233-256 and 263-282 from LipL41.

Full size image

Detection of B and T cell epitopes

B cell epitope was confirmed by Western blot assay as described in the methods. As shown in Figure 1B and 1C, all recombinant phages containing epitopes of OmpL1 or LipL41 reacted with the serum against leptospire (L. interrogans strain 56601), rOmpL1 and rLipL41. Through quantitative analysis using quantity one 4.6.3 software (Bio-Rad), we found that there were differences in the reactivity among the anti-sera of recombinant proteins and leptospire. The band representing OmpL1 residues 173-191 (OmpL1173-191) showed most significant reactivity with anti-rOmpL1 serum, and OmpL1297-320 was more reactive than the rest two epitopes. All the four recombinant phages reacted with the anti-leptospire serum. Phages containing OmpL187-98 reacted most significantly. The reactivity of phages containing OmpL159-78 and phages containing OmpL1297-320 was close. When the phage particles were incubated with anti-rLipL41 serum, the reactivity of phages containing epitope LipL41181-195 or LipL41263-282 was more remarkable than phages containing the other two epitopes. When incubating with anti-leptospire serum, the reactivity of phages containing LipL41233-256 was the lowest comparing to the other three epitopes. Five anti-leptospire sera from leptospire-infected humans were pooled together to test the reactivity against each B cell epitope. The result showed that epitope OmpL187-98 reacted the strongest among the four OmpL1 epitopes, and LipL41233-256 was the lowest among the four LipL41 epitopes (Figure 1D).

T cell epitope was examined using proliferation assay of CD4+ T cells. As shown in Figure 2, in comparison with that from PBS control mice, splenocytes harvested from rOmpL1- or rLipL41-immunized mice proliferated vigorously upon stimulation with phages expressing epitope peptides of OmpL1 or LipL41.

Figure 2
figure2

Proliferation rate of epitopes stimulated splenocytes. 5 × 104 splenocytes and 105 mitomycin-treated cells were mixed and stimulated with phage particles containing epitopes of OmpL1 (A) or LipL41 (B) to test the proliferation of the cells. Response to each antigen was presented as the mean value of three independent experiments. Splenocytes were isolated from PBS control mice to determine if the responses were OmpL1- or LipL41-specific. The cells stimulated with ConA and wild-type phages were used as controls. The data were representative of three independent experiments. Mix1 stands for the data from the epitope mixture of OmpL1 or LipL41 stimulating splenocytes from OmpL1- or LipL41-immunized mice. Mix2 stand for the data from the epitope mixture of both OmpL1 and LipL41 stimulating the splenocytes from OmpL1- or LipL41- immunized mice.

Full size image

Haake and his coworkers [16] previously reported that OmpL1 and LipL41 exhibited synergistic immunoprotection in Golden Syrian hamster model. To determine if there are also synergistic interactions among the epitope peptides, phages expressing each peptide of OmpL1 and LipL41 were pooled together and were used to stimulate the splenocytes. As shown in Figure 2, proliferation of splenocytes stimulated with the 8-epitope mixture (mix2) was more significant comparing to single-epitope phages or 4-epitope mixture of OmpL1 or LipL41 alone (mix1).

Evaluation of cytokine secretion in splenocytes induced by OmpL1- or LipL41-derived epitopes

ELISA assay was employed to determine the in vitro polarization of T helper cells. Cells from both OmpL1- and LipL41-immunized mice released large amount of IFN-γ but not IL-4 comparing to cells from PBS control mice (Figure 3). OmpL1173-191 epitope showed the strongest activity of stimulation, and other three OmpL1 epitopes showed similar abilities in the stimulation of IFN-γ secretion. Among the LipL41 epitopes, the secretion of IFN-γ in the cell cultures was induced by LipL41181-195, LipL41233-256 and LipL41263-282 to the similar level; all of them were stronger than LipL4130-48. When the 4 epitopes of OmpL1 were pooled together to stimulate the splenocytes, the secretion of IFN-γ cytokine in the splenocyte supernatants was mildly increased. Phages expressing each epitope of LipL41 failed to stimulate the secretion of IFN-γ or IL-4 (Figure 3B).

Figure 3
figure3

Cytokine profiles of T cells from mice spleen. Splenocytes from recombinant OmpL1 (A) or LipL41 (B) immunized mice were isolated 10 days after the last immunization and were stimulated with epitopes from corresponding proteins in vitro for 72 hours. Mix stand for the data from the epitope mixture of OmpL1 or LipL41 stimulating the splenocytes from OmpL1- or LipL41- immunized mice. Each value is representative of 3 mice in triplicates.

Full size image

Discussion

Leptospira interrogans causes disease in both animals and humans throughout the world. Leptospirosis in humans may be fatal due to the involvement of severe damage to multiple organs such as liver, lung, kidney and brain and is an increasing concern to the public health [24].

L. interrogans can rapidly disseminate to multiple organs to induce programmed cell death [25, 26]. The essential properties of a vaccine are safe, immunogenic, and effective in the prevention of leptospiral infection at both acute and carrier state. It has been a challenge to develop an effective and safe L. interrogans vaccine [27]. The currently available vaccines include multiple-valence inactivated leptospiral vaccine and subunit leptospiral vaccines [28]. However, these vaccines often have serious adverse effects [29]. And more importantly, most recombinant protein vaccines used against Leptospira in animals are serovar-specific and therefore their efficacy is limited when Leptospira of a different serovar is circulating [30]. The current emphasis in research laboratories is to discover conserved antigens that may induce long term protection across the species or serovars of Leptospira. A better understanding of the mechanisms of the humoral as well as cell-mediated immune responses that are protective during leptospirosis of animals or human is critical to the development of a good leptospiral vaccine.

Epitopes are small particular segments in antigen molecules which usually affect the antigenic specificity of the cellular and humoral immune responses. Epitopes are attracting in the development of leptospiral vaccines, because it is convenient to make a seasonal vaccine by simply changing the formulations of the epitopes of relevant species. There are two types of epitopes of antigens, linear and conformational. A linear or a sequential epitope is an epitope that is recognized by the antibodies by its linear sequence of amino acids, and a conformational epitope is the sequences of subunits composing an antigen (usually amino acids of a protein antigen) that directly binds to a receptor of the immune system [31, 32]. Commonly, T cell epitopes are regulated by antigen presenting cells (APC) to induce cellular immune response [20]. B cell epitopes including linear and conformational structure mostly induce humoral immune response [33, 34]. Multi-epitope peptide vaccine has become an attractive strategy in the development of vaccines against pathogens. Usually, a good epitope vaccine contains both B cell and T cell epitopes.

in silico epitope prediction is a useful tool in the development of new vaccine formulations [35–37]. We set out to identify combined T and B cell epitopes of the leptospiral outer membrane proteins which are closely associated with leptospirosis. In silico epitope prediction led to the identification of four combined T and B cell epitopes of OmpL1 and four combined T and B cell epitopes of LipL41, respectively. The predicted epitopes were distributed along the entire protein sequence of each outer membrane protein. We compared the sequences of these epitopes to the sequences of 15 official Chinese standard strains, and found that all the epitopes were identical to the corresponding regions of OmpL1 and LipL41 of these different Leptospira strains. To confirm B cell epitopes, we used phage display system and Western blot analysis which were efficient methods in the study of B cell epitopes [38]. Our result showed that these selected epitopes were specifically recognized by the antibodies in the rabbit sera against Leptospira interrogans, rOmpL1 or LipL41 but the reactivity of each epitope to the antibodies was different. We speculate that this might be due to the interference of the recognition by the recombinant proteins still present in the sera. Pathogenic microorganisms induce humoral immune responses during infection, which specifically responses to the antigens through specific interactions between the antibodies and the epitopes of the antigens [39]. Recognition of the epitopes by antisera from immunized BALB/c mice was confirmed, suggesting that these epitopes displayed by phages resemble the ones in the native antigen protein. In this study, we have shown that T and B cell combined epitopes of leptospiral outer membrane proteins OmpL1 and LipL41 induced leptospire-specific immune responses, which suggests that these epitopes instead of entire proteins may be used to develop leptospiral vaccines.

CD4+ T lymphocytes play a critical role in the host immune responses during bacterial infection [40, 41]. CD4+ T cells have been shown to differentiate into Th1, Th2 and lately Th17 (important to intracellular bacteria) cells. Th1 cells are characterized by their production of IFN-γ and are involved in cellular immunity [42, 43], and Th2 cells produce IL-4 and are required for humoral immunity [44]. In this experiment, the secretion of IFN-γ was more distinct than that of IL-4 when the splenocytes were stimulated with the epitopes. We did not detect any significant secretion of IL-4 in epitope-stimulated splenocyte cultures. It is possible that the levels of IL-4 were below detection limit. The results implied that the selected epitopes were BALB/c-specific Th1-type epitope. Immune protection against leptospires in mice is primarily correlated with Th1-mediated immunity and IFN-γ secretion [45]. This result is consistent with our previous findings on Leptospira antigens LipL32 and LipL21 proteins[22], suggesting that epitopes of outer membrane proteins (eg, OmpL1, LipL21, LipL32 and LipL41) can induce strong cell-mediated immune response as well humoral immune responses. These epitopes may help us to investigate the role of Th1 or Th2 responses in the pathogenesis and immunity during Leptospira interrogans infection.

Conclusions

The Western blot data present here indicated that the combined T and B cells epitopes in outer membrane proteins of L. interrogans can be recognized by antibodies in the sera from leptospire-infected patients or rabbits immunized with recombinant proteins of outer membrane proteins. The data from T cell proliferation assay and cytokines secretion analysis showed that the selected epitopes can induce a Th1- orientated response. The present study revealed that peptides OmpL1173-191 of OmpL1 and LipL41233-256 of LipL41 are both T cell and B cell epitopes which collaborate in the production of antibodies against leptospire and induction of lymphocyte differentiation. The identification of these immune dominant epitopes may greatly facilitate the development of novel leptospiral vaccines which may provide protections across different serogroups or serovars.

References

  1. 1.

    McBride AJ, Athanazio DA, Reis MG, Ko AI: Leptospirosis. Curr Opin Infect Dis. 2005, 18 (5): 376-386. 10.1097/01.qco.0000178824.05715.2c.

  2. 2.

    Palaniappan RU, Ramanujam S, Chang YF: Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. 2007, 20 (3): 284-292. 10.1097/QCO.0b013e32814a5729.

  3. 3.

    Lindenstrøm T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P: Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol. 2009, 182 (12): 8047-8055. 10.4049/jimmunol.0801592.

  4. 4.

    Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin C: Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun. 2001, 69: 7550-7558. 10.1128/IAI.69.12.7550-7558.2001.

  5. 5.

    Srinivasan A, Nanton M, Griffin A, McSorley SJ: Culling of activated CD4 T cells during typhoid is driven by Salmonella virulence genes. J Immunol. 2009, 182 (12): 7838-7845. 10.4049/jimmunol.0900382.

  6. 6.

    Faine S, Adler B, Bolin C, Perolat P: Pathogenesis, virulence, immunity. Leptospira and Leptospirosis. 1999, MediSci, Melbourne, Vic. Australia, 73-91. 2

  7. 7.

    Nascimento AL, Ko AI, Martins EA, Monteiro-Vitorello CB, Ho PL, Haake DA, Verjovski-Almeida S, Hartskeerl RA, Marques MV, Oliveira MC, Menck CF, Leite LC, Carrer H, Coutinho LL, Degrave WM, Dellagostin OA, El-Dorry H, Ferro ES, Ferro MI, Furlan LR, Gamberini M, Giglioti EA, Góes-Neto A, Goldman GH, Goldman MH, Harakava R, Jerônimo SM, Junqueira-de-Azevedo IL, Kimura ET, Kuramae EE, Lemos EG, Lemos MV, Marino CL, Nunes LR, de Oliveira RC, Pereira GG, Reis MS, Schriefer A, Siqueira WJ, Sommer P, Tsai SM, Simpson AJ, Ferro JA, Camargo LE, Kitajima JP, Setubal JC, Van Sluys MA: Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol. 2004, 186 (7): 2164-2172. 10.1128/JB.186.7.2164-2172.2004.

  8. 8.

    Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP: Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature. 2003, 422 (6934): 888-893. 10.1038/nature01597.

  9. 9.

    Bulach DM, Zuerner RL, Wilson P, Seemann T, McGrath A, Cullen PA, Davis J, Johnson M, Kuczek E, Alt DP, Peterson-Burch B, Coppel RL, Rood JI, Davies JK, Adler B: Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci USA. 2006, 103 (39): 14560-14565. 10.1073/pnas.0603979103.

  10. 10.

    Picardeau M, Bulach DM, Bouchier C, Zuerner RL, Zidane N, Wilson PJ, Creno S, Kuczek ES, Bommezzadri S, Davis JC, McGrath A, Johnson MJ, Boursaux-Eude C, Seemann T, Rouy Z, Coppel RL, Rood JI, Lajus A, Davies JK, Médigue C, Adler B: Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One. 2008, 3 (2): e1607-10.1371/journal.pone.0001607.

  11. 11.

    Cullen PA, Haake DA, Adler B: Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev. 2004, 28 (3): 291-318. 10.1016/j.femsre.2003.10.004.

  12. 12.

    Haake DA, Champion CI, Martinich C, Shang ES, Blanco DR, Miller JN, Lovett MA: Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp. J Bacteriol. 1993, 175 (13): 4225-4234.

  13. 13.

    Shang ES, Summers TA, Haake DA: Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun. 1996, 64 (6): 2322-2330.

  14. 14.

    Dong H, Hu Y, Xue F, Sun D, Ojcius DM, Mao Y, Yan J: Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol. 2008, 8: 223-10.1186/1471-2180-8-223.

  15. 15.

    Guerreiro H, Croda J, Flannery B, Mazel M, Matsunaga J, Galvão Reis M, Levett PN, Ko AI, Haake DA: Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun. 2001, 69 (8): 4958-4968. 10.1128/IAI.69.8.4958-4968.2001.

  16. 16.

    Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, Wagar EA: Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun. 1999, 67 (12): 6572-6582.

  17. 17.

    Ding W, Yan J, Mao YF: Genotyping of LipL41 genes from Leptospira interrogans serogroups and immunological identification of the expression products. Chin J Microbiol Immunol. 2004, 24 (11): 859-865.

  18. 18.

    Xu Y, Yan J, Mao YF, Li LW, Li SP: Genotypes of the OmpL1 gene from the dominant serogroups of Leptospira interrogans in China and construction of prokaryotic expression system of the gene and immunological identification of the recombinant protein. Chin J Microbiol Immunol. 2004, 24 (6): 439-444.

  19. 19.

    Lin X, Chen Y, Yan J: Recombinant multiepitope protein for diagnosis of leptospirosis. Clin Vaccine Immunol. 2008, 15 (11): 1711-1714. 10.1128/CVI.00189-08.

  20. 20.

    Singh H, Raghava GPS: ProPred: Prediction of HLA-DR binding sites. Bioinformatics. 2001, 17 (12): 1236-1237. 10.1093/bioinformatics/17.12.1236.

  21. 21.

    Lin X, Chen Y, Lu Y, Yan J, Yan J: Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. Diagn Microbiol Infect Dis. 2009, 63 (3): 237-242. 10.1016/j.diagmicrobio.2008.10.012.

  22. 22.

    Lin X, Zhao J, Qian J, Mao Y, Pan J, Li L, Peng H, Luo Y, Yan J: Identification of immunodominant B- and T-cell combined epitopes in outer membrane lipoproteins LipL32 and LipL21 of Leptospira interrogans. Clin Vaccine Immunol. 2010, 17 (5): 778-783. 10.1128/CVI.00405-09.

  23. 23.

    Day LA: Conformations of single-stranded DNA and coat protein in fd bacteriophage as revealed by ultraviolet absorption spectroscopy. J Mol Biol. 1969, 39 (2): 265-277. 10.1016/0022-2836(69)90316-7.

  24. 24.

    Dutta TK, Christopher M: Leptospirosis-an overview. J Assoc Physicians India. 2005, 53: 545-551.

  25. 25.

    Barocchi MA, Ko AI, Reis MG, McDonald KL, Riley LW: Rapid translocation of polarized MDCK cell monolayers by leptospira ubterrigabs, an invasive but nonintracellular pathogen. Infect Immun. 2002, 70 (12): 6926-6932. 10.1128/IAI.70.12.6926-6932.2002.

  26. 26.

    Jin D, Ojcius DM, Sun D, Dong H, Luo Y, Mao Y, Yan J: Leptospira interrogans induces apoptosis in macrophages via caspase-8- and caspase-3 dependent pathways. Infect Immun. 2009, 77 (2): 799-809. 10.1128/IAI.00914-08.

  27. 27.

    Gordon PJ: Control of leptospirosis by vaccination. Vet Rec. 2002, 150 (13): 420-

  28. 28.

    Wang Z, Jin L, Wegrzyn A: Leptospirosis vaccines. Microb Cell Fact. 2007, 6 (1): 39-10.1186/1475-2859-6-39.

  29. 29.

    Thongboonkerd V: Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev Mol Diagn. 2008, 8 (1): 53-61. 10.1586/14737159.8.1.53.

  30. 30.

    Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G: Evidence of crossprotection within Leptospira interrogans in an experimental model. Vaccine. 2000, 19 (1): 86-94. 10.1016/S0264-410X(00)00129-8.

  31. 31.

    Goldsby R, Kindt TJ, Osborne BA, Janis K: Antigens. Immunology. 2003, New York: W. H. Freeman and Company, 57-75. 5

  32. 32.

    Wang LF, Yu M: Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets. 2004, 5 (1): 1-15. 10.2174/1389450043490668.

  33. 33.

    Conway JF, Watts NR, Belnap DM, Cheng N, Stahl SJ, Wingfield PT, Steven AC: Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding. J Virol. 2003, 77 (11): 6466-6473. 10.1128/JVI.77.11.6466-6473.2003.

  34. 34.

    Malm M, Rollman E, Ustav M, Hinkula J, Krohn K, Wahren B, Blazevic V: Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. Viral Immunol. 2005, 18 (4): 678-688. 10.1089/vim.2005.18.678.

  35. 35.

    Fonseca CT, Cunha-Neto E, Kalil J, Jesus AR, Correa-Oliveira R, Carvalho EM, Oliveira SC: Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells. Mem Inst Oswaldo Cruz. 2004, 99 (5 Suppl 1): 63-66.

  36. 36.

    Iwai LK, Yoshida M, Sidney J, Shikanai-Yasuda MA, Goldberg AC, Juliano MA, Hammer J, Juliano L, Sette A, Kalil J, Travassos LR, Cunha-Neto E: In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paraccocidioides brazilienses frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals. Mol Med. 2003, 9 (9-12): 209-219.

  37. 37.

    Panigada M, Sturniolo T, Besozzi G, Boccieri MG, Sinigaglia F, Grassi GG, Grassi F: Identification of a promiscuous T cell epitope in Mycobacterium tuberculosis Mce proteins. Infect Immun. 2002, 70 (1): 79-85. 10.1128/IAI.70.1.79-85.2002.

  38. 38.

    Rowley MJ, O'Connor K, Wijeyewickrema L: Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions. Biotechnol Annu Rev. 2004, 10: 151-188. full_text.

  39. 39.

    Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y: Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs. 2007, 21 (3): 145-156. 10.2165/00063030-200721030-00002.

  40. 40.

    Chinen J, Shearer WT: Basic and clinical immunology. J Allergy Clin Immunol. 2005, 116 (2): 411-418. 10.1016/j.jaci.2005.05.010.

  41. 41.

    Haque A, Blum JS: New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases. J Biol Regul Homeost Agents. 2005, 19 (3-4): 93-104.

  42. 42.

    Schroder K, Hertzog PJ, Ravasi T, Hume DA: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004, 75 (2): 163-189. 10.1189/jlb.0603252.

  43. 43.

    Kita M: Role of IFN-gamma in nonviral infection. Nippon Rinsho. 2006, 64 (7): 1269-1274.

  44. 44.

    Zhou L, Chong MM, Littman DR: Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009, 30 (5): 646-655. 10.1016/j.immuni.2009.05.001.

  45. 45.

    Vernel-Pauillac F, Merien F: Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun. 2006, 74 (7): 4172-4179. 10.1128/IAI.00447-06.

Download references

Acknowledgements

We thank Prof. Iain C. Bruce for reading our manuscript. We are thankful to Dr. Jing Qian for the assistance with the study. This work was supported by grants from "AIDS and viral hepatitis and other major infectious diseases prevention and control" special project (2008ZX10004-015) and State Key Laboratory for Diagnosis and Treatment of Infectious Diseases.

Author information

Affiliations

  1. Department of Medical Microbiology and Parasitology, School of Medicine, Zhejiang University, 388 Yuhangtang Road, Hangzhou, 310058, PR China

    • Xu'ai Lin
    • , Aihua Sun
    • , Ping Ruan
    • , Zhe Zhang
    •  & Jie Yan

  2. Basic Medical Microbiology Division, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, School of Medicine, Zhejiang University, Hangzhou, 310058, PR China

    • Jie Yan

  3. Faculty of Basic Medicine, Zhejiang Medical College, Hangzhou, 310053, PR China

    • Aihua Sun

  4. Department of Medical Microbiology and Parasitology, Medical School of Shaoxing University, Shaoxing, 312000, PR China

    • Ping Ruan

Authors

  1. Search for Xu'ai Lin in:

  2. Search for Aihua Sun in:

  3. Search for Ping Ruan in:

  4. Search for Zhe Zhang in:

  5. Search for Jie Yan in:

Corresponding author

Correspondence to Jie Yan.

Additional information

Authors' contributions

LXA designed the work, performed the research study, and prepared the manuscript. SAH and RP participated in all experimental work. ZZ was involved in the revision of the manuscript. YJ designed and supervised the research study. All authors read and approved the final version of the manuscript.

Electronic supplementary material

Additional file 1: PCR amplification of epitopes. Predicted epitope fragments of OmpL1 and LipL41 were amplified from genomic DNA of Lai strain. M is the DNA ladder. 1-4 are the epitope fragments 59-78, 87-98, 173-191 and 297-320 of OmpL1. 5-8 are the epitope fragments 30-48, 181-195, 233-256 and 263-282 of LipL41. (PPT 187 KB)

Additional file 2: PCR confirmation of epitope insertion in the recombinant phage. The inserted epitope fragment in recombinant M13KE was confirmed by colony PCR. M is the DNA ladder. 1 is the fragment amplified from wild type phage M13KE, 2-5 are the epitope fragments 59-78, 87-98, 173-191 and 297-320 of OmpL1. 6-9 are the epitope fragments 30-48, 181-195, 233-256 and 263-282 of LipL41. (PPT 195 KB)

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • Outer Membrane Protein
  • Cell Epitope
  • Leptospirosis
  • Epitope Peptide
  • Recombinant Phage

BMC Microbiology

ISSN: 1471-2180

Contact us